Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.41
+0.15 (0.87%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
-0.34 (-1.95%)
After-hours: Dec 5, 2025, 7:48 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.13 billion as of December 5, 2025. Its market cap has increased by 122.06% in one year.
Market Cap
1.13B
Enterprise Value
782.61M
1-Year Change
122.06%
Ranking
Category
Stock Price
$17.41
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.13B, an increase of 34.12%. That is a compound annual growth rate of 6.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.13B | 165.90% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |